Skip to content
HCN Grants Est. 2026
No. HT942526NFRPEHDA · Defense Health Agency Contracting Activity - DHACA
Open

DoW Neurofibromatosis Exploration-Hypothesis Development Award

grants.gov listing ↗ Full announcement (NOFO) ↗
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated

At a glance

No plain-language summary yet for this grant — the official description below is the best source.

What it funds

  • Science and Technology and other Research and Development
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. Distinctive Features: • Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities. • Preliminary Data: Preliminary and/or published data is encouraged but not required.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide